Regenerative medicine (RM) companies are multiplying in number—and they are multiplying fast.
There's now an astounding 1,050+ companies worldwide that are developing regenerative medicine (RM) products for therapeutic use in humans.
The rapid growth of RM companies is being driven by:- Unprecedented rates of RM clinical trials
- Accelerated pathways for RM product approvals
- Flourishing approvals for CAR-T cell therapies
- Increased interest among pharmaceutical companies in RM partnerships
- Potential for RM therapies to revolutionize healthcare
Because the number of companies can vary depending on the definition of regenerative medicine that is applied, we define regenerative medicine companies as those pursuing therapeutic approaches that involve:
|
|
|
|
While we have seen organizations apply a looser definition of regenerative medicine, we believe this targeted definition provides the most accurate coverage of the Regenerative Medicine (RM) Industry and its annual rate of growth.
Unsurprisingly, it takes our analysts countless hours of research to uncover newly formed companies from across the globe. We also utilize translators to discover companies doing business in other languages and crowd-source feedback from BioInformant's partners, clients, and readership.
The end result is the world’s only searchable, sortable database of regenerative medicine (RM) companies that is publicly available.
This database was originally developed in-house for our own purposes, but we have had more and more clients requesting access to it.
For the next 48 hours, you can claim the "Global Regenerative Medicine Industry Database 2022" for 50% off (only $97):
Remember to act soon, before this offer expires.
Be Great,
The BioInformant Team
p.s. More than 250 clients have rated this database with 5.0 Stars (98.33%).
p.p.s. Of course, your investment is backed by our Money Back Guarantee.
|
|
|
